Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India Interventions modified University of Massachusetts, WorcesterNot applicable NCT07231432
  2. Minor: NICU-to-Home Dyadic Support for Very Preterm Infants and Families Start date pushed from Nov 16, 2026 to Nov 30, 2026 University of MinnesotaNot applicable NCT07820462
  3. Minor: Cognitive Training · Eating Disorders Study completion pushed from Jul 2026 to Jul 2032 Norwegian University of Science and TechnologyNot applicable NCT03808467
  4. Minor: Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL Trial completed Acerta Pharma BVPhase 3 NCT02475681
  5. Minor: IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Trial status changed: Not Yet Recruiting → Active, Not Recruiting Sinovac Biotech Co., LtdPhase 3 NCT07416110
  6. Minor: Mesothelin-Targeting Logic-gated CAR T, · Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing A2 Biotherapeutics Inc.Phase 1/2 NCT06051695
  7. Minor: SIM0278 · Moderate to Severe Atopic Dermatitis Trial status changed: Not Yet Recruiting → Active, Not Recruiting Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 2 NCT07175233
  8. Minor: MAXPIRe · Axatilimab · Idiopathic Pulmonary Fibrosis (IPF) Trial completed Syndax PharmaceuticalsPhase 2 NCT06132256
  9. Minor: RGX-314 Gene Therapy Administered in the Suprachoroidal Space · Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Trial completed AbbViePhase 2 NCT04567550
  10. Minor: FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) Trial completed Ferrer Internacional S.A.Phase 2 NCT06355531
  11. Minor: LY4268989 (MORF 057) in Healthy Participants Trial completed Eli Lilly and CompanyPhase 1 NCT07707375
  12. Minor: Research Into the Safety of a New Agent (VT-5006) · and Without Parkinson's Disease Trial completed Vertero TherapeuticsPhase 1 NCT07310264
  13. Minor: IBI3011 Trial completed Innovent Biologics (Suzhou) Co. Ltd.Phase 1 NCT07295496
  14. Minor: Cardiac Performance System (CPS) Trial completed Sensydia CorporationNot specified NCT06870591
  15. Minor: Vimida Trial completed Gaia AGNot applicable NCT06251518
  16. Minor: Specified Drug-use Survey of Leqvio for s.c. Injection Trial completed Novartis PharmaceuticalsNot specified NCT06275724
  17. Minor: Probiotic Supplementation on Stress and Anxiety in Students Trial completed Nordic Biotic Sp. z o.o.Not applicable NCT07470645
  18. Minor: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Enrollment closed, study ongoing Edwards LifesciencesNot applicable NCT04097145
  19. Minor: Gastrointestinal Discomfort and Infections in Healthy Term Infants Trial completed Ausnutria Hyproca B.V.Not specified NCT06744699
  20. Minor: Specified Drug-use Surveillance of Fabhalta Capsules Trial completed Novartis PharmaceuticalsNot specified NCT06606314
  21. Minor: New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors Enrollment closed, study ongoing National Cancer Institute (NCI)Phase 1/2 NCT05053971
  22. Minor: 9-Valent Human Papillomavirus Recombinant Vaccine · Idiopathic CD4 T Cell Lymphocytopenia Trial completed National Institute of Allergy and Infectious Diseases (NIAID)Phase 2 NCT03519464
  23. Minor: Emicizumab · Type 3 Von Willebrand Disease Primary completion pushed from Apr 30, 2027 to Oct 6, 2027 Hoffmann-La RochePhase 3 NCT06998524
  24. Minor: Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer Primary completion pushed from Dec 12, 2029 to Mar 13, 2030 GlaxoSmithKlinePhase 3 NCT07740720
  25. Minor: IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD Trial status changed: Not Yet Recruiting → Active, Not Recruiting The Royal Wolverhampton Hospitals NHS TrustNot specified NCT07175454